Chipscreen(SH:688321) Shang Hai Zheng Quan Bao·2025-08-25 20:28Core Viewpoint - The company has released its 2025 semi-annual report, which reflects its financial status and operational results, ensuring compliance with relevant regulations and internal management systems [5][14]. Group 1: Company Overview - The company is Shenzhen Micron Biotech Co., Ltd., with stock code 688321 and is listed on the Shanghai Stock Exchange [4]. - The company has undergone no changes in its controlling shareholder or actual controller during the reporting period [4]. Group 2: Financial Data - The company reported a total fundraising amount of RMB 1,021.5 million from its initial public offering in 2019, with a net amount of RMB 945.19 million after deducting related expenses [20]. - The company raised RMB 500 million through convertible bonds in 2022, with a net amount of RMB 484.54 million after expenses [21]. Group 3: Fund Management - As of June 30, 2025, the company had a remaining balance of RMB 15.27 million from the 2019 IPO funds and RMB 17.92 million from the 2022 convertible bonds [22]. - The company has established a fund management system to ensure that the raised funds are stored in dedicated accounts and used for their intended purposes [22]. Group 4: Fund Usage - The company has used RMB 49.8 million from its IPO funds to replace self-raised funds for investment projects [28]. - The company has not used any idle funds to temporarily supplement working capital as of June 30, 2025 [32]. Group 5: Project Adjustments - The company has adjusted the timeline for certain fundraising investment projects, extending the expected completion date from December 31, 2024, to December 31, 2026 [46].